human liver cancer tissue microarray (lv1505a) Search Results


tissue microarray cat. lv1505a  (TissueArray.com LLC)
90
TissueArray.com LLC tissue microarray cat. lv1505a
Association between TESC gene expression and clinical prognosis. A High and low expression groups, established by dividing the TCGA-LIHC on the basis of median expression of CD133, CD90, and EpCAM. Thirteen intersecting differentially expressed genes were identified, with high expression of TESC and QSOX1 being noted in LCSCs from spheroid cultures. B TESC’s high expression in the TCGA-LIHC was significantly correlated with shorter overall survival (OS). C TESC expression in various cancers compared with that in adjacent normal tissues (if available), assessed using TIMER2.0. D RNA expression of the TESC gene in liver cancer and normal liver tissues from the ICGC database. E Protein expression of the TESC gene in liver cancer and normal liver tissues from the CPTAC database. F Immunohistochemistry (IHC) image of TESC in liver cancer and adjacent liver tissues of tissue <t>microarray</t> (Cat. <t>LV1505a,</t> TissueArray.Com). Scale bar, 60 μm. * P < 0.05; ** P < 0.01; *** P < 0.001
Tissue Microarray Cat. Lv1505a, supplied by TissueArray.com LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tissue microarray cat. lv1505a/product/TissueArray.com LLC
Average 90 stars, based on 1 article reviews
tissue microarray cat. lv1505a - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Association between TESC gene expression and clinical prognosis. A High and low expression groups, established by dividing the TCGA-LIHC on the basis of median expression of CD133, CD90, and EpCAM. Thirteen intersecting differentially expressed genes were identified, with high expression of TESC and QSOX1 being noted in LCSCs from spheroid cultures. B TESC’s high expression in the TCGA-LIHC was significantly correlated with shorter overall survival (OS). C TESC expression in various cancers compared with that in adjacent normal tissues (if available), assessed using TIMER2.0. D RNA expression of the TESC gene in liver cancer and normal liver tissues from the ICGC database. E Protein expression of the TESC gene in liver cancer and normal liver tissues from the CPTAC database. F Immunohistochemistry (IHC) image of TESC in liver cancer and adjacent liver tissues of tissue microarray (Cat. LV1505a, TissueArray.Com). Scale bar, 60 μm. * P < 0.05; ** P < 0.01; *** P < 0.001

Journal: Clinical and Experimental Medicine

Article Title: TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer

doi: 10.1007/s10238-024-01469-y

Figure Lengend Snippet: Association between TESC gene expression and clinical prognosis. A High and low expression groups, established by dividing the TCGA-LIHC on the basis of median expression of CD133, CD90, and EpCAM. Thirteen intersecting differentially expressed genes were identified, with high expression of TESC and QSOX1 being noted in LCSCs from spheroid cultures. B TESC’s high expression in the TCGA-LIHC was significantly correlated with shorter overall survival (OS). C TESC expression in various cancers compared with that in adjacent normal tissues (if available), assessed using TIMER2.0. D RNA expression of the TESC gene in liver cancer and normal liver tissues from the ICGC database. E Protein expression of the TESC gene in liver cancer and normal liver tissues from the CPTAC database. F Immunohistochemistry (IHC) image of TESC in liver cancer and adjacent liver tissues of tissue microarray (Cat. LV1505a, TissueArray.Com). Scale bar, 60 μm. * P < 0.05; ** P < 0.01; *** P < 0.001

Article Snippet: F Immunohistochemistry (IHC) image of TESC in liver cancer and adjacent liver tissues of tissue microarray (Cat. LV1505a, TissueArray.Com).

Techniques: Gene Expression, Expressing, RNA Expression, Immunohistochemistry, Microarray

Reduced stemness characteristics in liver cancer cell lines due to downregulation of TESC. A Correlation between TESC expression and CSC biomarkers. B Knockdown of the TESC gene in HepG2 and Huh7 cell lines. C Western blot revealing the protein expression of CSC biomarkers CD133, EpCAM, and SOX2 after TESC knockdown. D IHC staining of liver cancer microarray (Cat. LV1505a, TissueArray.Com) for the correlation between TESC, CD133 and SOX2. Scale bar, 60 μm. E–G Fisher’s exact test showed a positive correlation between TESC and CD133 (E) , TESC and SOX2 (F) , and CD133 and SOX2 (G) . H Sphere formation assay in stable TESC knockdown cell lines and TESC-overexpressing cell lines (left panel). The statistical bar graphs present the sphere numbers (right panel). * P < 0.05; ** P < 0.01; *** P < 0.001

Journal: Clinical and Experimental Medicine

Article Title: TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer

doi: 10.1007/s10238-024-01469-y

Figure Lengend Snippet: Reduced stemness characteristics in liver cancer cell lines due to downregulation of TESC. A Correlation between TESC expression and CSC biomarkers. B Knockdown of the TESC gene in HepG2 and Huh7 cell lines. C Western blot revealing the protein expression of CSC biomarkers CD133, EpCAM, and SOX2 after TESC knockdown. D IHC staining of liver cancer microarray (Cat. LV1505a, TissueArray.Com) for the correlation between TESC, CD133 and SOX2. Scale bar, 60 μm. E–G Fisher’s exact test showed a positive correlation between TESC and CD133 (E) , TESC and SOX2 (F) , and CD133 and SOX2 (G) . H Sphere formation assay in stable TESC knockdown cell lines and TESC-overexpressing cell lines (left panel). The statistical bar graphs present the sphere numbers (right panel). * P < 0.05; ** P < 0.01; *** P < 0.001

Article Snippet: F Immunohistochemistry (IHC) image of TESC in liver cancer and adjacent liver tissues of tissue microarray (Cat. LV1505a, TissueArray.Com).

Techniques: Expressing, Knockdown, Western Blot, Immunohistochemistry, Microarray, Tube Formation Assay